Topiramate
Product Images NDC 70934-022

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Topiramate (NDC 70934-022). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Denton Pharma, Inc. Dba Northwind Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

70934 022 60 Rev A 07 19

70934 022 60 Rev A 07 19
FDA Label Image

Chemical-structure (Chemical Structure)

Chemical-structure (Chemical Structure)
FDA Label Image

Figure-1jpg (Figure 1)

Figure-1jpg (Figure 1)
FDA Label Image

Figure-2 (Figure 2)

Figure-2 (Figure 2)
This text provides data on the change in monthly migraine period rates during a double-blind phase for a study using topiramate at various doses and a placebo. The study is identified as either Study 10 or Study 11. The results of the study are denoted by statistical significance indicators.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.